论文部分内容阅读
目的观察康复新液联合口服解痉液防治食管癌放射性食管炎的疗效。方法 68例中晚期食管癌患者,随机分为实验组(35例)和对照组(33例)。实验组在口服解痉液基础上加用康复新液(康复新液10 ml+解痉液20 ml)防治放射性食管炎,对照组口服解痉液(解痉液20 ml)防治放射性食管炎。对比两组临床疗效。结果实验组和对照组防治放射性食管炎的有效率分别为91.43%和69.70%,两组比较差异具有统计学意义(P<0.05)。结论康复新液联合解痉液,对放射性食管炎具有比较明显的预防治疗作用,能明显降低食管癌放疗中放射性食管炎的发生率以及严重程度,值得临床推广。
Objective To observe the curative effect of Kangfuxin Solution combined with oral antispasmodic solution in preventing and treating esophageal cancer esophagitis. Methods Sixty-eight patients with advanced esophageal cancer were randomly divided into experimental group (35 cases) and control group (33 cases). The experimental group was treated with oral solution of antispasmodic fluid (Kangfuxin solution 10 ml + antispasmodic solution 20 ml) for the prevention and treatment of radiation esophagitis, while the control group was given oral solution of antispasmodic solution (antispasmodic solution 20 ml) for prevention and treatment of radiation esophagitis. Compare two groups clinical curative effect. Results The effective rates of prevention and treatment of radiation esophagitis in experimental group and control group were 91.43% and 69.70%, respectively. The differences between the two groups were statistically significant (P <0.05). Conclusion Kangfuxin solution combined with antispasmodic solution has obvious preventive and therapeutic effects on radiation esophagitis and can significantly reduce the incidence and severity of radiation esophagitis in radiotherapy of esophageal cancer and is worthy of clinical promotion.